PD-L1 inhibitor (anti-PD-L1)

PD-L1 inhibitor · Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PD-L1 inhibitor (anti-PD-L1), covering 2011-12-13 to 2011-12-13. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Biomarker Study of Anti-PDL-1 in Advanced Melanoma [Phase 1]